MedPath
FDA Approval

Neomycin and Polymyxin B Sulfates and Dexamethasone

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
August 14, 2018
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Neomycin(3.5 mg in 1 mL)
Polymyxin B(10000 [USP'U] in 1 mL)
Dexamethasone(1 mg in 1 mL)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Aidarex Pharmaceuticals

Aidarex Pharmaceuticals LLC

801503249

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Neomycin and Polymyxin B Sulfates and Dexamethasone

Product Details

NDC Product Code
33261-551
Application Number
ANDA062341
Marketing Category
ANDA (C73584)
Route of Administration
OPHTHALMIC
Effective Date
August 14, 2018
WATERInactive
Code: 059QF0KO0RClass: IACT
NeomycinActive
Code: 057Y626693Class: ACTIMQuantity: 3.5 mg in 1 mL
SODIUM CHLORIDEInactive
Code: 451W47IQ8XClass: IACT
POLYSORBATE 20Inactive
Code: 7T1F30V5YHClass: IACT
Code: 19371312D4Class: ACTIMQuantity: 10000 [USP'U] in 1 mL
Code: 7S5I7G3JQLClass: ACTIBQuantity: 1 mg in 1 mL
HYPROMELLOSE 2910 (4000 MPA.S)Inactive
Code: RN3152OP35Class: IACT
HYDROCHLORIC ACIDInactive
Code: QTT17582CBClass: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32IClass: IACT
BENZALKONIUM CHLORIDEInactive
Code: F5UM2KM3W7Class: IACT
© Copyright 2025. All Rights Reserved by MedPath